Safety profile in the Argus  ®  II Retinal Prosthesis System post-market patients (I)

descriptionPublicationkeyboard_double_arrow_right Conference object 01 Jan 2013Embargo end date: 18 Oct 2013 English Publisher:German Medical Science GMS Publishing House

Authors: Cosendai, G; Walter, P; Augustin, A; Kirchhof, B; Sahel, J; Da Cruz, L; Rizzo, S; +1 Authors

doi: 10.3205/13doc160 , 10.3205/13artvis31

Safety profile in the Argus ® II Retinal Prosthesis System post-market patients (I)

- Summary
- Subjects
- Metrics

Abstract

Purpose: The Argus II Retinal Prosthesis System (Argus II) is the first and only artificial retina approved for market use (2011 CE mark in Europe, 2013 US FDA approval) and has since been implanted in 22 patients blinded by Retinitis Pigmentosa in 7 surgical centers in Italy, Germany, Saudi Arabia,[for full text, please go to the a.m. URL]

26. Internationaler Kongress der Deutschen Ophthalmochirurgen

Keywords

ddc: 610, 610 Medical sciences; Medicine

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average

Found an issue? Give us feedback

0

Average

Green

Beta

SDGs Suggest

3. Good health

Beta

SDGs:

3. Good health,

Related to Research communities

Knowmad Institut